NCT03855722招募中不适用
Remote Ischaemic Preconditioning in Transplantation (RIPTRANS) - A Prospective Randomized Controlled Trial
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 496
- 试验地点
- 2
- 主要终点
- DGF
研究概览
简要总结
Remote ischemic preconditioning (RIPC) is a concept where remotely induced ischemia produces protection against ischemia-reperfusion injury in a remote organ. RIPC has been studied extensively in animal models and heart surgery, but it's benefit in transplantation has been studied less. The primary aim of this study is to find out whether RIPC performed in a donor in donation after brain-death (DBD) could improve delayed graft function rate of kidney transplants.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Brain-dead organ donor with a plan of harvesting at least one kidney
排除标准
- •Haemodynamically unstable donor
- •Age below 18 years
- •Planned organ recipients are recruited to another prospective trial, which prevents participation in this trial.
- •All organ recipients receiving organs (kidney, liver, pancreas-kidney, heart, lungs) from a randomized donor will be recruited providing that the recipient surgery is performed at Helsinki University Hospital, recipient is over 18 years old, and recipient gives written informed consent to participate in the trial.
结局指标
主要结局
DGF
时间窗: 7 days
Delayed graft function of kidney allografts defined as postoperative dialysis within 1 week from transplantation
次要结局
- Combined Pancreas-Kidney allografts: kidney graft survival(at 3 months, 1 year, 2 year, 5 year, 10 year, and 20 year)
- Kidney allografts: BPAR(within 1 year)
- Liver allografts: MEAF-score at 3rd POD(3rd post-operative day)
- Pancreas allografts: Acute rejection(within 1 year)
- Lung allograft: CLAD-free survival(at 1 year, 2 year, 5 year, 10 year, and 20 year)
- Liver allografts: graft survival(at 1 year, 2 year, 5 year, 10 year, and 20 year)
- Pancreas allografts: Death-censored Pancreatic allograft survival(at 1 year, 2 year, 5 year, 10 year, and 20 year)
- Combined Pancreas-Kidney allografts: eGFR(at 3 months, 1 year, 2 year, 5 year, 10 year, and 20 year)
- Pancreas allografts: HbA1c(at 3 months, 1 year, 2 year, 5 year, 10 year, and 20 year)
- Pancreas allografts: Pancreatic allograft survival(at 1 year, 2 year, 5 year, 10 year, and 20 year)
- Heart allograft: proBNP at 1 week(at 1 week)
- Heart allograft: Primary graft dysfunction(within 24 hours after transplantation)
- Heart allograft: acute rejection(within 1 year)
- Heart allograft: graft survival(at 1 year, 2 year, 5 year, 10 year, and 20 year)
- Lung allograft: Primary graft dysfunction(within 72 hours)
- Lung allograft: graft survival(at 1, 2, 5, 10 and 20 year)
- Heart allograft: TnI at 6 hours(at 6 hours)
- Kidney allografts: death-censored graft survival(at 3 months, 1 year, 2 year, 5 year, 10 year, and 20 year)
- Combined Pancreas-Kidney allografts: death-censored kidney graft survival(at 3 months, 1 year, 2 year, 5 year, 10 year, and 20 year)
- Liver allografts: Postoperative biliary complications(within 1 year)
- Liver allografts: Posttransplantation kidney injury(within 1 week, at 3 months, 1 year)
- Liver allografts: BPAR(within 1 year)
- Kidney allografts: eGFR(at 3 months, 1 year, 2 year, 5 year, 10 year, and 20 year)
- Combined Pancreas-Kidney allografts: Kidney BPAR(within 1 year)
- Kidney allografts: graft survival(at 3 months, 1 year, 2 year, 5 year, 10 year, and 20 year)
- Heart allograft: Vasculopathy-free survival(at 1 year, 2 year, 5 year, 10 year, and 20 year)
- Lung allograft: Acute rejection(within 1 year)
研究者
Ville Sallinen
MD, PhD, Adj. Prof., Consultant
Helsinki University Central Hospital
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Effects of Remote Ischemic Preconditioning During Free Flap ReconstructionRemote Ischemic PreconditioningNCT03474952Seoul National University Hospital50
已完成
不适用
Liver Protection of RIPC in Pediatric Living Donor Liver TransplantationHepatic Ischemic and Reperfusion InjuryNCT02830841RenJi Hospital208
尚未招募
不适用
Protective Effect of RIPC Against Negative Inflammatory Response and Organ Dysfunction After Cardiovascular Surgery (Panda VII)Cardiopulmonary BypassCardiovascular DiseasesInflammatory Response During Cardiac SurgeryNCT06707350Nanjing Medical University500
已完成
不适用
RIPC During Free Flap With Preoperative RadiotherapyIschemic Reperfusion InjuryOther Reconstructive SurgeryRadiotherapyNCT03535623Seoul National University Hospital44
已完成
不适用
Remote Ischemic Preconditioning as a New Method of NephroprotectionAcute Kidney InjuryNCT03205410Medical University of Lodz50